Results 151 to 160 of about 14,994 (217)

High incidence of clinical malaria among asymptomatic Plasmodium falciparum infected children receiving SMC with sulfadoxine-pyrimethamine and amodiaquine (SP + AQ) in Koulikoro, Mali. [PDF]

Malar J
Sanogo D, Toure M, Keita M, Kane F, Keita S, Sanogo I, Diawara SI, Tangara CO, Coulibaly H, Cisse B, Thiam SM, Diakite M, Sogoba N, Doumbia S.   +13 more
europepmc   +1 more source

Uptake and Effectiveness of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine during Pregnancy in Africa: A Scoping Review. [PDF]

Diseases
Berchie GO, Doe PF, Azu TD, Agyeiwaa J, Owusu G, Boso CM, Yeboa NK, Agyare DF, Aboh IK, Nabe B, Ofori GO, Anumel B, Kagbo JE, Alhassan A, Offei FO, Opoku-Danso R, Abraham SA, Amoadu M, Hagan JE.   +18 more
europepmc   +1 more source

The demand for intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine in the Volta Region of Ghana. [PDF]

PLoS One
Asem L, Abdulia AG, Assuming PO, Abeka-Nkrumah G.   +3 more
europepmc   +1 more source

Prevalence of molecular markers of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from West Africa during 2012-2022. [PDF]

Sci Rep
Zhou R, Li S, Ji P, Ruan S, Liu Y, Yang C, Qian D, He Z, Wang D, Lu D, Zhang H, Deng Y.   +11 more
europepmc   +1 more source

Projected uptake of sulfadoxine-pyrimethamine for perennial malaria chemoprevention in children under 2 years of age in nine sub-Saharan African countries: an epidemiologically-based 5-year forecast analysis. [PDF]

Malar J
Audibert C, Hugo P, Gosling R, Eddis C, Center M, Tchouatieu AM.   +5 more
europepmc   +1 more source

Pharmacometric evaluation of amodiaquine-sulfadoxine-pyrimethamine and dihydroartemisinin-piperaquine seasonal malaria chemoprevention in northern Uganda

Bonnington C, Nuwa A, Theiss-Nyland K, Kajubi R, Kamya MR, Nankabirwa J, Ebong C, Rassi C, Nabakooza J, Opigo J, Salandindi D, Odongo M, Sararat C, Watson JA, Suwannasin K, Proux S, Koesukwiwat U, Tarning J, Imwong M, Tibenderana J, Nosten F, White N.   +21 more
europepmc   +1 more source

Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a three-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine plus amodiaquine versus artesunate monotherapy among asymptomatic children 3-5 years of age in Cameroon. [PDF]

BMC Infect Dis
Martinez-Vega R, Mbacham WF, Ali I, Nji A, Mousa A, Beshir KB, Chopo-Pizarro A, Kaur H, Okell L, Hansson H, Hocke EF, Alifrangis M, Gosling R, Roper C, Sutherland C, Chico RM.   +15 more
europepmc   +1 more source

Acceptability of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine plus dihydroartemisinin-piperaquine in Papua New Guinea: a qualitative study. [PDF]

Malar J
Lufele E, Pascoe S, Mengi A, Auwun A, Neuendorf N, Bolnga JW, Laman M, Rogerson SJ, Thriemer K, Unger HW.   +9 more
europepmc   +1 more source

A health facility-based assessment of the ancillary benefit for prevention of anaemia at term of intermittent preventive therapy with sulfadoxine-pyrimethamine in pregnancy. [PDF]

Ghana Med J
Asare BA, Asare G.
europepmc   +1 more source